Novartis drug Afinitor DISPERZ receives FDA approval to treat TSC-associated partial-onset seizures Read more
Protalex Initiates Fourth Cohort Dosing of Phase 1/2 Study of PRTX-100 in Immune Thrombocytopenia Read more
Allele Receives Tissue Bank License for Manufacturing and Distribution of cGMP-compliant iPSCs Read more
AbbVie Announces Global Resolution of HUMIRA (adalimumab) Patent Disputes with Samsung Bioepis Read more